scorecardresearch
Add as a preferred source on Google
Thursday, December 11, 2025
TopicSputnik

Topic: Sputnik

Sputnik V found to be less effective against Beta variant in lab tests, study says

Blood samples from recipients of both doses of Sputnik showed that the vaccine was 6 times less effective against the Beta variant in laboratory tests.

Mixing vaccines without evidence a ‘dangerous’ trend, WHO’s Soumya Swaminathan says

Swaminathan warned that it will be a chaotic situation in countries if citizens start deciding ‘when and who should be taking a second, third or fourth dose’.

Russian Direct Investment Fund, Panacea Biotec launch production of Sputnik V in India

The first batch produced at Panacea Biotec's facilities in Himachal Pradesh will be shipped to Russia for quality control. Full-scale production is expected to start this summer.

Amid vaccine shortage, Delhi govt writes to Dr Reddy’s Labs for 67 lakh Sputnik doses

Earlier Deputy Chief Minister Manish Sisodia claimed that Covaxin manufacturer Bharat Biotech has refused to provide additional doses to the national capital.

Dr Reddy’s administers first dose of Sputnik V vaccine in India

The imported doses of the Covid vaccine, which received regulatory clearance on 13 May, are presently priced at a maximum retail price of Rs 948, with 5% GST per dose.

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Oversupply of Covid shot in Russia but skepticism dogs Sputnik V vaccine drive

Not many are taking the Sputnik V vaccine with the low numbers being blamed on Russians’ distrust of officialdom dating back to the Soviet era and doubts over the vaccine.

Pakistan close to granting approval to Russia’s Sputnik Covid vaccine

Pakistan has already ordered 1.2 million doses of Chinese Sinopharm vaccine, with deliveries to start 31 January. It has also given approval to AstraZeneca shot for private use.

‘No safety concerns’ — Dr Reddy’s seeks DCGI nod to continue Sputnik V phase 3 trials

No safety concerns identified during Sputnik V mid-stage trial, data has been submitted to Drugs Controller General of India for a review, Dr. Reddy’s says in a statement.

Russia’s Sputnik V vaccine has no peer-reviewed data yet. Question is — would you take it

Russia hasn’t released late-stage phase 3 data on its vaccine. That said, what we do know about Sputnik V and its design should give us some degree of confidence.

On Camera

India’s long war with Maoists has a huge void — no number of dead bodies can fill it

Weak governance, corruption and poverty continue to define tribal life in India. The introduction of industrial and mining projects has benefited contractors, politicians and officials more than Adivasis.

Niti Aayog CEO has a message for power stakeholders. Buckle up for surge to feed EVs, data centres

Clean energy is “no longer the sideshow, it is the show”, BVR Subrahmanyam told the Odisha summit, warning India to lead the global shift or risk others’ tech dominance.

Dubai Tejas crash revives focus on advanced, fully automated safety systems

Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.